| ICOS Corporation to
Release 2004 Financial Results on February 3,
2005
January 19, 2005
BOTHELL, Wash.--(BUSINESS WIRE)--Jan. 19, 2005--ICOS
Corporation (Nasdaq:ICOS) will announce its
2004 full year and fourth quarter financial
results on Thursday, February 3, 2005, after
the market close. Following the announcement,
company management will host a webcast discussion
of financial results and related matters at
4:30 p.m. EST. ICOS will also provide financial
guidance and discuss plans for 2005. Access
to the discussion can be obtained as follows.
LIVE Access on February 3, 2005, 4:30 p.m.
EST:
-- Phone (612) 332-0923; Passcode 763452.
-- Webcast connection through the ICOS
Web site at www.icos.com in the Investor/Events
section.
REPLAY Access:
-- Phone replay accessible from February 3,
2005, 8:00 p.m. EST, for 24 hours at (320) 365-3844;
Passcode 763452.
-- Webcast replay, available through February
10, 2005, on the ICOS Web site at www.icos.com
in the Investor/Events section.
Additional information on ICOS, including past
press releases, is also available at www.icos.com.
About ICOS Corporation:
ICOS Corporation, a biotechnology company headquartered
in Bothell, Washington, is dedicated to bringing
innovative therapeutics to patients. ICOS is
marketing its first product, Cialis(R) (tadalafil),
through Lilly ICOS LLC, for the treatment of
erectile dysfunction.
ICOS is working to develop treatments for serious
unmet medical conditions such as chronic obstructive
pulmonary disease, benign prostatic hyperplasia,
cancer and inflammatory diseases.
The forward-looking statements contained in
this press release represent ICOS' judgment
as of the date of this release. ICOS undertakes
no obligation to publicly update any forward-looking
statements. The biotechnology and pharmaceutical
businesses are risky and there can be no assurance
that any particular product or product candidate
will be a commercial success.
source:-http://home.businesswire.com
|
